Cell Therapeutics, Foreign Investors Net Sell 3,000 Shares... Stock Price Down 5.83%
Cellma Therapeutics ranked among the top searched stocks for 3 days within the past month.
As of 2:34 PM on the 4th, Cellma Therapeutics is trading at 8,080 KRW, down 5.83% from the previous day. This represents a 49.63% increase compared to December 4th. Cellma Therapeutics is known as a distributor of gift certificate discounts and dental materials.
Today, foreigners are tentatively recorded as net sellers of 3,000 shares. Over the past 5 days, individual investors have net sold 7,475 shares, while foreigners and institutions have net sold 25,372 shares and net bought 12,317 shares, respectively.
On December 30th, Cellma Therapeutics was an issue in the market with the headline "Bullish... Variant COVID-19 virus spreading to the United States."
Hot Picks Today
!["It Has Now Crossed Borders": No Vaccine or Treatment as Bundibugyo Ebola Variant Spreads [Reading Science]](https://cwcontent.asiae.co.kr/asiaresize/93/2026052019230771274_1779272587.jpg)
"It Has Now Crossed Borders": No Vaccine or Treatment as Bundibugyo Ebola Variant Spreads [Reading Science]
- "Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
- "Am I Really in the Top 30%?" and "Worried About My Girlfriend in the Bottom 70%"... Buzz Over High Oil Price Relief Fund
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
※ Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
